z-logo
open-access-imgOpen Access
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases
Author(s) -
Melanie S. Joy,
Kimberly A. Dornbrook-Lavender,
Joyce Blaisdell,
Tandrea Hilliard,
Tammy Boyette,
Yichun Hu,
Susan L. Hogan,
Corina Candiani,
Ronald J. Falk,
Joyce A. Goldstein
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5axk-8481
Subject(s) - losartan , pharmacodynamics , medicine , genotype , pharmacology , primary (astronomy) , biology , receptor , angiotensin ii , pharmacokinetics , genetics , gene , physics , astronomy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here